Merck, ABE1307, Anti-CHD1L Antibody

General description
KLH-conjugated linear peptide corresponding to the Helicase C-terminal domain of human CHD1L.
~78/110 kDa observed. Uncharacterized band(s) may appear in some lysates. Uncharacterized band(s) may appear in some lysates.
Application
Epitope: Helicase C-terminal domain
Biochem/physiol Actions
This isoform has been observed to react with isoform 1 and 3.
Physical form
Purified rabbit polyclonal in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
Preparation Note
Stable for 1 year at 2-8°C from date of receipt.
Analysis Note
Evaluated by Western Blotting in A549 cell lysate.

Western Blotting Analysis: 0.5 µg/mL of this antibody detected CHD1L in 10 µg of A549 cell lysate.
Other Notes
Human. Predicted to react with Mouse, Rat based on 100% sequence homology.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.